中證(zheng)網(wang)訊 漢(han)森(sen)(sen)制藥(yao)(002412)3月(yue)30日午(wu)間(jian)發布公(gong)告稱,公(gong)司于2018年3月(yue)29日接到控股股東新疆漢(han)森(sen)(sen)通知,獲悉新疆漢(han)森(sen)(sen)所持(chi)有本公(gong)司的(de)部分股份(fen)已辦理了質(zhi)押(ya)手續,本次質(zhi)押(ya)13,000,000股,本次質(zhi)押(ya)股數占(zhan)其所持(chi)公(gong)司股份(fen)的(de)比例的(de)10.42%。
截至公(gong)告披露(lu)日,新疆漢森共(gong)持有公(gong)司股(gu)(gu)份124,709,523股(gu)(gu),占公(gong)司總(zong)(zong)股(gu)(gu)本的42.13%;本次質押(ya)股(gu)(gu)份共(gong)13,000,000股(gu)(gu),占公(gong)司總(zong)(zong)股(gu)(gu)本的4.39%;累計質押(ya)股(gu)(gu)份114,274,500股(gu)(gu),占公(gong)司總(zong)(zong)股(gu)(gu)本的38.61%,占其所持有公(gong)司股(gu)(gu)份的91.63%。(張(zhang)典(dian)閣(ge))